James Pike

1.8k total citations
71 papers, 1.3k citations indexed

About

James Pike is a scholar working on Pathology and Forensic Medicine, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, James Pike has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 11 papers in Epidemiology and 11 papers in Psychiatry and Mental health. Recurrent topics in James Pike's work include Multiple Sclerosis Research Studies (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). James Pike is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). James Pike collaborates with scholars based in United Kingdom, United States and Switzerland. James Pike's co-authors include Richard Perry, Ross J. Baldessarini, David Price, James Piercy, Edward L. Jones, Angela Williams, Jacqueline R. Carranza Rosenzweig, Elizabeth V. Hillyer, Stephen Kay and Mike Thomas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

James Pike

67 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Pike United Kingdom 19 328 304 271 223 151 71 1.3k
Laurent Balardy France 16 621 1.9× 161 0.5× 154 0.6× 49 0.2× 164 1.1× 58 1.7k
Ariane K. Kawata United States 20 220 0.7× 613 2.0× 110 0.4× 339 1.5× 29 0.2× 42 1.4k
Morris S. Gold United States 20 477 1.5× 181 0.6× 133 0.5× 72 0.3× 65 0.4× 46 1.5k
Carol Blendowski United States 5 232 0.7× 248 0.8× 467 1.7× 58 0.3× 74 0.5× 6 1.8k
Luís Lizán Spain 19 163 0.5× 174 0.6× 34 0.1× 111 0.5× 176 1.2× 94 1.2k
Jung Eun Yoo South Korea 23 200 0.6× 132 0.4× 263 1.0× 144 0.6× 32 0.2× 89 1.5k
María Jesús García de Yébenes Spain 22 90 0.3× 223 0.7× 50 0.2× 102 0.5× 107 0.7× 63 1.2k
Yunxia Wang China 15 99 0.3× 148 0.5× 154 0.6× 68 0.3× 29 0.2× 48 1.5k
Markus M. Luedi Switzerland 27 111 0.3× 65 0.2× 214 0.8× 60 0.3× 49 0.3× 165 2.3k
Angela Juby Canada 22 182 0.6× 171 0.6× 53 0.2× 103 0.5× 90 0.6× 55 1.6k

Countries citing papers authored by James Pike

Since Specialization
Citations

This map shows the geographic impact of James Pike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Pike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Pike more than expected).

Fields of papers citing papers by James Pike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Pike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Pike. The network helps show where James Pike may publish in the future.

Co-authorship network of co-authors of James Pike

This figure shows the co-authorship network connecting the top 25 collaborators of James Pike. A scholar is included among the top collaborators of James Pike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Pike. James Pike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hainan, et al.. (2024). Healthcare resource utilization and economic burden of multiple sclerosis in Chinese patients: results from a real-world survey. Scientific Reports. 14(1). 15183–15183. 1 indexed citations
2.
Touma, Zahi, Karen H. Costenbader, David R. Bell, et al.. (2024). Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity. BMC Rheumatology. 8(1). 22–22. 2 indexed citations
3.
Higgins, Victoria, et al.. (2023). Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH. Health and Quality of Life Outcomes. 21(1). 113–113. 4 indexed citations
4.
Fishman, Joel E., Victoria Higgins, James Piercy, & James Pike. (2023). PCR3 EQ-5D Utilities for Patients With Nonalcoholic Steatohepatitis (NASH): A Comparison of Historical Utilities to a Recent Real-World Multi-Country Patient Survey. Value in Health. 26(12). S448–S448.
5.
Antonini, Angelo, Rajesh Pahwa, Per Odin, et al.. (2022). Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries. Neurology and Therapy. 11(1). 303–318. 10 indexed citations
6.
Schein, Jeff, Christy R. Houle, Annette Urganus, et al.. (2022). The Impact of Agitation in Dementia on Caregivers: A Real-World Survey. Journal of Alzheimer s Disease. 88(2). 663–677. 15 indexed citations
7.
8.
Chan, Xin Hui S, James Pike, Borimas Hanboonkunupakarn, et al.. (2021). The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis. PLoS Medicine. 18(9). e1003766–e1003766. 6 indexed citations
9.
Mellor, Jennifer M., et al.. (2020). PRO9 RELATIONSHIP BETWEEN PROGRESSIVE SUPRANUCLEAR PALSY AND HEALTHCARE RESOURCE UTILIZATION. Value in Health. 23. S330–S330. 1 indexed citations
10.
Criscitiello, Carmen, Dean Spurden, A. Rider, et al.. (2020). 82P A multinational study of real-world treatment patterns among patients with early stage HR+/HER2- breast cancer (BC). Annals of Oncology. 31. S42–S43. 2 indexed citations
11.
12.
Pike, James, Gregory A. Maglinte, A. Rider, et al.. (2017). Predicting EQ-5D Utility Index Scores for Gastric Cancer Patients in Japan: A Preliminary Model. Value in Health. 20(9). A447–A447. 1 indexed citations
13.
Lee, Andrew, James Pike, Michael Edwards, et al.. (2017). Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients. Neurology and Therapy. 6(1). 79–90. 13 indexed citations
14.
15.
Serafini, Paul, Eddie Jones, & James Pike. (2016). Assessment of Patient Preferences in the Treatment of Relapsing-Remitting Multiple Sclerosis in Public and Private Systems in Latin America. Value in Health. 19(7). A435–A435. 1 indexed citations
16.
Mutebi, Alex, James Pike, Neel Shah, et al.. (2016). The Use Of Migraine Prophylaxis Treatment: Analysis Of Clinical Practice Data From The United States, Germany, France, And Japan. Value in Health. 19(3). A68–A68. 1 indexed citations
17.
18.
Higgins, Victoria, et al.. (2014). Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. International Journal of COPD. 9. 551–551. 36 indexed citations
19.
Small, Mark, James Piercy, James Pike, & Annamaria Cerulli. (2014). Incremental Burden of Disease in Patients Diagnosed with Pulmonary Arterial Hypertension Receiving Monotherapy and Combination Vasodilator Therapy. Advances in Therapy. 31(2). 168–179. 10 indexed citations
20.
Bacon, Donald R. & James Pike. (1993). Shelf Wars: A Grocery Channel Simulation. Developments in Business Simulation and Experiential Learning: Proceedings of the Annual ABSEL conference. 20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Balardy Breakdown of academic impact, for papers by Ariane K. Kawata Breakdown of academic impact, for papers by Morris S. Gold Breakdown of academic impact, for papers by Carol Blendowski Breakdown of academic impact, for papers by Luís Lizán Breakdown of academic impact, for papers by Jung Eun Yoo Breakdown of academic impact, for papers by María Jesús García de Yébenes Breakdown of academic impact, for papers by Yunxia Wang Breakdown of academic impact, for papers by Markus M. Luedi Breakdown of academic impact, for papers by Angela Juby
Rankless by CCL
2026